Vyome Holdings (HIND) EBT (2015 - 2026)
Vyome Holdings (HIND) posted quarterly EBT of -$1.3 million for Q1 2026, down 186.05% year-over-year from $1.5 million in Q1 2025, and up 7.98% quarter-over-quarter from -$1.4 million in Q4 2025.
Vyome Holdings (HIND) EBT (2015 - 2026) Analysis & Trends
Vyome Holdings' EBT history runs 12 years deep, the most recent figure standing at -$1.3 million for Q1 2026.
- In Q1 2026, EBT fell 186.05% year-over-year to -$1.3 million; the TTM figure through Mar 2026 stood at -$13.9 million (down 304.7% YoY), while the FY2025 annual figure was -$85.6 million, down 1107.82% from the prior year.
- EBT for Q1 2026 stood at -$1.3 million, up from -$1.4 million in the prior quarter.
- The five-year high for EBT was $1.5 million in Q1 2025, with the low at -$16.5 million in Q4 2022.
- The 5-year median for EBT is -$2.6 million (2025), against an average of -$4.6 million.
- Peak annual rise in EBT reached 167.97% in 2025, while the deepest fall reached 446.03% in 2025.
- Vyome Holdings' EBT stood at -$16.5 million in 2022, then surged by 89.91% to -$1.7 million in 2023, then dropped by 5.34% to -$1.8 million in 2024, then advanced by 21.14% to -$1.4 million in 2025, then climbed by 7.98% to -$1.3 million in 2026.
- Business Quant data shows HIND's EBT at -$1.3 million in Q1 2026, -$1.4 million in Q4 2025, and -$8.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 | -865,891.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.01 Mn |
| Mar 31, 2026 | -1.27 Mn |
| Dec 31, 2025 | -1.38 Mn |
| Sep 30, 2025 | -8.60 Mn |
| Jun 30, 2025 | -2.62 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | -1.76 Mn |
| Sep 30, 2024 | -1.58 Mn |
| Jun 30, 2024 | -1.58 Mn |
| Mar 31, 2024 | -2.18 Mn |
| Dec 31, 2023 | -1.67 Mn |
| Sep 30, 2023 | -3.53 Mn |
| Jun 30, 2023 | -3.49 Mn |
| Mar 31, 2023 | -2.65 Mn |
| Dec 31, 2022 | -16.53 Mn |
| Sep 30, 2022 | -12.55 Mn |
| Jun 30, 2022 | -9.44 Mn |
| Mar 31, 2022 | -8.09 Mn |
| Dec 31, 2021 | -37.55 Mn |
| Sep 30, 2021 | -17.16 Mn |